News | November 06, 2009

BIOTRONIK Announces Results of REPLACE Registry

November 4, 2009 — BIOTRONIK Inc. this week announced the results from site preparation, antibiotic use and infection sub-analysis from the REPLACE Registry. The results, based on analysis of 1,031 patients undergoing elective replacement of their implanted cardiac rhythm management (CRM) device, provides important insight on techniques for surgical site preparation and antibiotic use in device-replacement procedures.

The REPLACE Registry was designed to evaluate the rate of complications from CRM device replacement and upgrade from all CRM manufacturers. The REPLACE Registry is the first large, prospective study to look at the factors that influence infection rates in device replacement.

The sub-analysis included 1,031 replacement procedures with representative devices from five CRM manufacturers. The infection rates from the first group of patients in the REPLACE Registry were presented at the poster sessions of the Infectious Diseases Society of America Scientific Sessions. Two factors were identified that exhibited significantly different infection rates. The first factor was preoperative skin preparation. Skin preparation with povidone-iodine was associated with an increased rate of infection (2.1 percent) compared with chlorhexidine-containing compounds (0.2 percent). The second factor was post-operative antibiotic use. The incidence of infection among patients receiving no postoperative antibiotics (0.5 percent) was lower than in those receiving parenteral antibiotics postoperatively (2.3 percent).

“Postoperative IV antibiotics are often given to patients in an attempt to decrease the risk of infection,” noted Daniel Uslan, M.D., assistant clinical professor at UCLA and member of the REPLACE Registry steering committee. “In the REPLACE Registry, there did not seem to be any benefit to doing so.”

“Infections occurred uncommonly in the REPLACE Registry. It is interesting that a variety of antibiotic prophylaxis measures were used by the site investigators who participated,” added Jeanne Poole, M.D., national principal investigator for the REPLACE Registry. “All patients received intravenous antibiotics. These data will contribute significantly to the body of literature available on device related infections.”

For more information: www.biotronik.com

Related Content

Mexican Doctors Safely Reuse Donated Pacemakers After Sterilization

Mexican government reports conclude more than half of the population does not have access to social security or private insurance that covers a pacemaker implant, and 44 percent live in poverty. Recycling donated, explanted pacemakers offers a new option for these patients.

News | Pacemakers| November 10, 2017
Mexican doctors have safely reused donated pacemakers after sterilization, shows a study presented at the 30th Mexican...
Pacemakers and Other Cardiac Devices Can Help Solve Forensic Cases
News | Pacemakers| June 20, 2017
Pacemakers and other cardiac devices can help solve forensic cases, according to a study presented at the European...
Videos | Pacemakers| May 23, 2017
Vivek Reddy, M.D., director of cardiac arrhythmia services and professor of medicine, cardiology, Mount Sinai Hospita
micra leadless pacemaker
Feature | Pacemakers| May 16, 2017
May 16, 2017 - The preliminary results for the Medtronic Micra Transcatheter Pacing System (TPS) Post-Approval Regist
Videos | Pacemakers| May 16, 2017
This video, provided by Medtronic, demonstrates the implantation of Micra transcatheter pacing system (TPS).
closed loop stimulation, DDD-CLS, ACC17, SPAIN trial
Feature | Pacemakers| March 22, 2017
March 22, 2017 — Patients with recurrent fainting episodes (syncope) who received a pacemaker delivering a pacing pro
Micra leadless pacemaker, CMS, medicare reimbursement
News | Pacemakers| March 10, 2017
March, 10, 2017 - Medtronic announced that the U.S.
Medtronic, Micra TPS pacemaker, transcatheter pacing system, global clinical trial, one-year results, ESC 2016
News | Pacemakers| August 29, 2016
August 29, 2016 — Medtronic plc announced new long-term results from the Medtronic Micra Transcatheter Pacing System
Medtronic, Micra TPS pacemaker, Global Clinical Trial, Cardiostim 2016
News | Pacemakers| June 09, 2016
Medtronic plc announced new results from the Medtronic Micra Transcatheter Pacing System (TPS) Global Clinical Trial in...
Medtronic, Micra TPS, transcatheter pacing system, pacemaker, Jersey Shore University Medical Center, New Jersey first
News | Pacemakers| June 06, 2016
Jersey Shore University Medical Center, part of Meridian CardioVascular Network, is the first hospital in New Jersey to...
Overlay Init